A detailed history of Bokf, Na transactions in Boston Scientific Corp stock. As of the latest transaction made, Bokf, Na holds 7,373 shares of BSX stock, worth $665,118. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,373
Previous 3,065 140.55%
Holding current value
$665,118
Previous $236,000 161.44%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $314,311 - $361,872
4,308 Added 140.55%
7,373 $617,000
Q2 2024

Aug 07, 2024

BUY
$67.33 - $77.71 $25,383 - $29,296
377 Added 14.03%
3,065 $236,000
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $24,998 - $29,781
-434 Reduced 13.9%
2,688 $184,000
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $42,608 - $50,641
876 Added 39.0%
3,122 $180,000
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $731,167 - $796,578
-14,568 Reduced 86.64%
2,246 $118,000
Q2 2023

Aug 21, 2023

SELL
$49.72 - $54.64 $18,794 - $20,653
-378 Reduced 2.2%
16,814 $909,000
Q1 2023

May 11, 2023

SELL
$45.09 - $50.03 $804,405 - $892,535
-17,840 Reduced 50.92%
17,192 $860,000
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $98,504 - $117,577
2,490 Added 7.65%
35,032 $1.62 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $363,722 - $1.09 Million
-9,908 Reduced 23.34%
32,542 $1.26 Million
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $20,721 - $27,694
-588 Reduced 1.37%
42,450 $1.58 Million
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $187,362 - $206,603
4,581 Added 11.91%
43,038 $1.91 Million
Q4 2021

Mar 11, 2022

SELL
$38.07 - $44.87 $250,234 - $294,930
-6,573 Reduced 14.6%
38,457 $1.63 Million
Q3 2021

Nov 10, 2021

BUY
$41.23 - $45.88 $891,516 - $992,063
21,623 Added 92.38%
45,030 $1.95 Million
Q1 2021

Apr 21, 2021

SELL
$35.27 - $39.67 $501,609 - $564,186
-14,222 Reduced 37.8%
23,407 $905,000
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $617,982 - $782,404
18,642 Added 98.18%
37,629 $1.35 Million
Q3 2020

Oct 30, 2020

BUY
$34.44 - $42.23 $6,061 - $7,432
176 Added 0.94%
18,987 $725,000
Q2 2020

Aug 12, 2020

SELL
$30.19 - $39.11 $46,885 - $60,737
-1,553 Reduced 7.63%
18,811 $661,000
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $12,501 - $22,123
484 Added 2.43%
20,364 $664,000
Q4 2019

Feb 12, 2020

SELL
$37.87 - $45.37 $360,636 - $432,058
-9,523 Reduced 32.39%
19,880 $899,000
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $487,025 - $524,962
12,082 Added 69.75%
29,403 $1.2 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $321,311 - $395,587
9,204 Added 113.39%
17,321 $744,000
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $26,327 - $32,600
800 Added 10.93%
8,117 $311,000
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $42,454 - $52,235
1,338 Added 22.38%
7,317 $259,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $38.63 $196,290 - $230,968
5,979 New
5,979 $231,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.